These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10654634)

  • 1. Strategies for study of the role of cycling on antimicrobial use and resistance.
    McGowan JE
    Infect Control Hosp Epidemiol; 2000 Jan; 21(1 Suppl):S36-43. PubMed ID: 10654634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial cycling: lessons learned from the aminoglycoside experience.
    Gerding DN
    Infect Control Hosp Epidemiol; 2000 Jan; 21(1 Suppl):S12-7. PubMed ID: 10654630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microbial genetics of antibiotic cycling.
    John JF; Rice LB
    Infect Control Hosp Epidemiol; 2000 Jan; 21(1 Suppl):S22-31. PubMed ID: 10654632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing antimicrobial resistance in intensive care units.
    Gandhi TN; DePestel DD; Collins CD; Nagel J; Washer LL
    Crit Care Med; 2010 Aug; 38(8 Suppl):S315-23. PubMed ID: 20647789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for decreasing multidrug antibiotic resistance: role of ototopical agents for treatment of middle ear infections.
    Klein JO
    Am J Manag Care; 2002 Oct; 8(14 Suppl):S345-52. PubMed ID: 12408220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units.
    Pierson CL; Friedman BA
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2 Suppl):19S-30S. PubMed ID: 1737439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?
    Kollef MH
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S82-8. PubMed ID: 16894520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance: factors and outcomes.
    Fish DN; Ohlinger MJ
    Crit Care Clin; 2006 Apr; 22(2):291-311, vii. PubMed ID: 16678001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of issues surrounding implementation of the Campaign to Prevent Antimicrobial Resistance in Healthcare Settings.
    Brinsley K; Sinkowitz-Cochran R; Cardo D;
    Am J Infect Control; 2005 Sep; 33(7):402-9. PubMed ID: 16153487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine cycling of antimicrobial agents as an infection-control measure.
    Fridkin SK
    Clin Infect Dis; 2003 Jun; 36(11):1438-44. PubMed ID: 12766840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals.
    Fridkin SK; Steward CD; Edwards JR; Pryor ER; McGowan JE; Archibald LK; Gaynes RP; Tenover FC
    Clin Infect Dis; 1999 Aug; 29(2):245-52. PubMed ID: 10476720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
    Hughes MG; Evans HL; Chong TW; Smith RL; Raymond DP; Pelletier SJ; Pruett TL; Sawyer RG
    Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance: consideration as an adverse drug event.
    Martin SJ; Micek ST; Wood GC
    Crit Care Med; 2010 Jun; 38(6 Suppl):S155-61. PubMed ID: 20502169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.
    Kollef MH
    Crit Care; 2005 Oct; 9(5):459-64. PubMed ID: 16277734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the efficacy of antimicrobial cycling programmes and patient isolation on dual resistance in hospitals.
    Chow K; Wang X; Curtiss R; Castillo-Chavez C
    J Biol Dyn; 2011 Jan; 5(1):27-43. PubMed ID: 22877228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial stewardship programs in health care systems.
    MacDougall C; Polk RE
    Clin Microbiol Rev; 2005 Oct; 18(4):638-56. PubMed ID: 16223951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriate use of antimicrobial agents: challenges and strategies for improvement.
    Niederman MS
    Crit Care Med; 2003 Feb; 31(2):608-16. PubMed ID: 12576973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence, selection and spread of resistance to antimicrobial agents used for growth promotion for food animals in Denmark.
    Aarestrup FM
    APMIS Suppl; 2000; 101():1-48. PubMed ID: 11125553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance in the intensive care unit: impact of new patterns.
    McGowan J; Tenover F
    Int J Clin Pract Suppl; 1998 Jun; 95():14-22. PubMed ID: 9796551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.